Weiss Multi-Strategy Advisers’s Roivant Sciences ROIV Stock Holding History
Bought
Maintained
Sold
Other funds holding ROIV
SIAU
QF
RCMNY
PSC
WP
Weiss Multi-Strategy Advisers's ROIV Position: Q1 2024 in Review
Weiss Multi-Strategy Advisers sold out of Roivant Sciences (ROIV) in Q1 2024, closing a stake of 263,519 shares — an estimated $2.96M sold.
Weiss Multi-Strategy Advisers first reported a position in ROIV in Q2 2023 and held it in 3 quarters. The position peaked at $2.96M in Q4 2023. 259 funds tracked by Wall St. Rank hold ROIV as of Q1 2024.
- Weiss Multi-Strategy Advisers reported no remaining Roivant Sciences position as of Q1 2024 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 263,519 Roivant Sciences shares in Q1 2024, an estimated $2.96M.
- Weiss Multi-Strategy Advisers first reported a position in Roivant Sciences in Q2 2023 and held it in 3 quarters.
- Weiss Multi-Strategy Advisers's Roivant Sciences position peaked at $2.96M in Q4 2023.
- 259 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2024.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2024.